Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Dr Reddy’s Debuts Two Revlimid Exclusives As Part Of Complete Launch In US
End Of Teva Exclusivity Period Opens Door For Several Lenalidomide ANDA Approvals
09 Sep 2022
•
By
Dean Rudge
Dr Reddy’s has launched multiple presentations of lenalidomide, two with exclusivity • Source: christitzeimaging.com / Alamy Stock Photo
More from Products
More from Generics Bulletin